Jefferies Financial Group upgraded shares of Omega Healthcare Investors (NYSE:OHI) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning, AR Network reports. They currently have $40.00 target price on the real estate investment trust’s stock, up from their previous target price of $35.00. Jefferies Financial Group also issued estimates for Omega Healthcare Investors’ FY2021 earnings at $3.19 EPS.
A number of other equities research analysts also recently weighed in on the stock. Mizuho lifted their price target on shares of Omega Healthcare Investors from $30.00 to $34.00 and gave the company a buy rating in a research report on Friday, October 2nd. Zacks Investment Research raised shares of Omega Healthcare Investors from a hold rating to a buy rating and set a $35.00 target price on the stock in a research note on Wednesday, October 14th. Wells Fargo & Company raised shares of Omega Healthcare Investors from an equal weight rating to an overweight rating and boosted their target price for the stock from $33.00 to $39.00 in a research note on Thursday, December 10th. JMP Securities raised shares of Omega Healthcare Investors from a market perform rating to an outperform rating and set a $43.00 price objective on the stock in a research note on Thursday, December 3rd. Finally, Bank of America raised shares of Omega Healthcare Investors from an underperform rating to a buy rating and boosted their price objective for the stock from $32.00 to $40.00 in a research note on Monday, November 30th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company. The stock has an average rating of Buy and a consensus price target of $35.53.
Shares of NYSE OHI traded down $0.27 during mid-day trading on Wednesday, hitting $35.35. The company had a trading volume of 129,516 shares, compared to its average volume of 2,116,217. The company has a market capitalization of $8.02 billion, a PE ratio of 51.62, a price-to-earnings-growth ratio of 2.63 and a beta of 1.03. The firm has a 50-day simple moving average of $36.77 and a two-hundred day simple moving average of $32.71. The company has a current ratio of 3.40, a quick ratio of 3.40 and a debt-to-equity ratio of 1.31. Omega Healthcare Investors has a one year low of $13.33 and a one year high of $45.22.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, October 29th. The real estate investment trust reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of $0.78 by ($1.18). The business had revenue of $81.21 million for the quarter, compared to the consensus estimate of $214.56 million. Omega Healthcare Investors had a return on equity of 3.78% and a net margin of 17.99%. The company’s revenue for the quarter was down 59.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.76 EPS. Sell-side analysts expect that Omega Healthcare Investors will post 3.15 earnings per share for the current fiscal year.
In other Omega Healthcare Investors news, CEO C Taylor Pickett sold 175,456 shares of Omega Healthcare Investors stock in a transaction dated Monday, December 28th. The shares were sold at an average price of $37.00, for a total value of $6,491,872.00. Following the completion of the transaction, the chief executive officer now directly owns 74,738 shares of the company’s stock, valued at $2,765,306. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Daniel J. Booth sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 30th. The shares were sold at an average price of $36.74, for a total transaction of $918,500.00. Following the transaction, the chief operating officer now directly owns 162,081 shares of the company’s stock, valued at $5,954,855.94. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 1,500 shares of company stock valued at $50,845 and sold 230,056 shares valued at $8,513,972. 1.16% of the stock is currently owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. ProShare Advisors LLC raised its position in shares of Omega Healthcare Investors by 4.2% in the 3rd quarter. ProShare Advisors LLC now owns 490,168 shares of the real estate investment trust’s stock valued at $14,676,000 after purchasing an additional 19,967 shares during the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $4,018,000. Pacer Advisors Inc. purchased a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $1,643,000. Engineers Gate Manager LP purchased a new stake in shares of Omega Healthcare Investors during the 2nd quarter valued at $268,000. Finally, IFM Investors Pty Ltd raised its position in Omega Healthcare Investors by 27.1% in the 3rd quarter. IFM Investors Pty Ltd now owns 19,910 shares of the real estate investment trust’s stock worth $596,000 after purchasing an additional 4,246 shares during the period. 67.93% of the stock is currently owned by institutional investors.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
See Also: Dead Cat Bounce
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.